Option chain shows key data for Mydecine Innovations Gr's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Mydecine Innovations Gr.

Mydecine Innovations Gr (OTC:MYCOF) Stock, Option Chain

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

2-17

Cannabis

News

Psychedelics

Health Care

MYDECINE INNOV GRP by MYDECINE INNOVATIONS GROUP INC.

MYCOF

Global psychedelic drugs market to reach $10.2 billion by 2028, driven by mental health needs and evolving regulatory support.

Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises

image006

Exclusives

ATAI

CMPS

CSE:HAVN

CSE:TRIP

CYBN

HAVLF

MNMD

RVVTF

SEEL

TRIP

RED LIGHT HOLLAND CORP by Red Light Holland Corp.

TRUFF

Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy.

EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves

Psyched New - option 1

Financing

Legal

Management

Global

AWKNF

CMND

DRUG

FLHLF

IXHL

MDXXF

Psychedelics Headlines: Trauma-Informed Care, Valentine&#39;s Day &amp; MDMA, Academics On Drugs And More

MYDECINE INNOVATNS GP INC by MYDECINE INNOVATIONS GROUP INC NEW

Mydecine Innovations Group Inc

Mydecine Innovations Gr

Mydecine Innovations

Comments

Mydecine Innovations Gr

Mydecine Innovations Gr (MYCOF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga